Skip to main content

4 Result(s)

within Article Remove this filter James R. Lambert Remove this filter

and

  1. Article

    Open Access

    MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells

    Current treatment for patients with metastatic melanoma include molecular-targeted therapies and immune checkpoint inhibitors. However, a subset of melanomas are difficult-to-treat. These melanomas include tho...

    Nabanita Mukherjee, Jenette Skees, Kaleb J. Todd, Drake A. West… in Cell Death & Disease (2020)

    Download PDF (3238 KB) View Article

  2. Article

    Open Access

    Efficient identification of mutations that potentially confer treatment resistance through computational derivation

    Christy M Gearheart, James R Lambert, Christopher C Porter in BMC Bioinformatics (2015)

    Download PDF (219 KB) View Article

  3. Article

    Endocrine Disrupting Activities of the Flavonoid Nutraceuticals Luteolin and Quercetin

    Dietary plant flavonoids have been proposed to contribute to cancer prevention, neuroprotection, and cardiovascular health through their anti-oxidant, anti-inflammatory, pro-apoptotic, and antiproliferative ac...

    Steven K. Nordeen, Betty J. Bona, David N. Jones, James R. Lambert… in Hormones and Cancer (2013)

    Download PDF (379 KB) View Article

  4. No Access

    Article

    Growth factors in benign prostatic hyperplasia: Basic science implications

    Benign prostatic hyperplasia (BPH) is the most common proliferative disease of the prostate of men in the United States. The histopathology of BPH strongly implicates local paracrine and autocrine growth facto...

    M. Scott Lucia, James R. Lambert in Current Urology Reports (2008)